FDA Inspection 1076171 — Robert A Feldman, MD
The FDA completed an inspection of Robert A Feldman, MD on Dec 13, 2018 in South Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 13, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- South Miami, FL (United States)
Additional Details
Clinical Investigator (CI)